ASX Announcements

Investor Presentation

Investor and Industry meetings in New York and in Atlanta, USA, June 2018

Download

Notice Under Section 708A

Notice Under Section 708A

Download

Appendix 3B

New issue announcement,
application for quotation of additional securities
and agreement

Download

Completion of Private Placement ~$7.9M Raised with SPP

Completion of Private Placement ~$7.9M Raised with SPP

Download

Quarterly Investor Call

To be held at 8:30am AEST, Thursday 10th May 2018.

Download

NOTICE UNDER SECTION 708A

Download

New issue announcement, application for quotation of additional securities and agreement

Download

QUARTERLY ACTIVITIES & CASHFLOW REPORT

We are pleased to release our Quarterly Cashflow report and update for the quarter ending 31 March 2018.

Download

First placement of APAS Independence into European lab

Following an extensive review of the APAS® AI technology in the Company’s facilities in Adelaide and at St Vincent’s Hospital in Melbourne, prestigious German facility Labor Dr Wisplinghoff in Cologne has commissioned its first APAS® Independence instrument. This production-ready instrument has shipped to Germany and will be commissioned by CCS technical staff with scientists at the Labor Dr Wisplinghoff facility, following the ECCMID meeting in Madrid on 21-24 April 2018.

Download

Presentation of APAS® Evaluation at 28TH ECCMID Conference

We are pleased to announce that data detailing the performance of the APAS®
Independence in a clinical setting was presented at the ECCMID meeting by Lisa Brenton of St Vincent’s Hospital, Melbourne.

Download

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25